1 New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer! Nov 23, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
Read More Apparatus FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit! Nov 24, 2024
Read More Medical New Targeted Radiotherapy For "Laser-Like" Precision Treatment Of Refractory Prostate Cancer With Fewer Side Effects! Nov 13, 2024
